Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,215 USD | +5,39 % | +6,44 % | -83,07 % |
23/04 | Transcript : CNS Pharmaceuticals, Inc. - Special Call | |
01/04 | CNS Pharmaceuticals, Inc. informa de los resultados del ejercicio cerrado el 31 de diciembre de 2023 | CI |
Resumen de negocios
Número de empleados: 4
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
John Climaco
CEO | Chief Executive Officer | 55 | 01/09/17 |
Director of Finance/CFO | 45 | 13/11/19 | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/12/17 |
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/01/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/01/18 |
John Climaco
CEO | Chief Executive Officer | 55 | 01/09/17 |
Faith Charles
CHM | Chairman | 62 | 03/01/23 |
Jeffry Keyes
BRD | Director/Board Member | 51 | 25/06/18 |
Bettina Cockroft
BRD | Director/Board Member | 57 | 08/05/23 |
Jerzy Gumulka
BRD | Director/Board Member | 75 | 08/11/17 |
Carl Evans
BRD | Director/Board Member | 77 | 09/07/18 |
Amy Mahery
BRD | Director/Board Member | - | 18/01 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 10 634 932 | 9 621 176 ( 90,47 %) | 0 | 90,47 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-83,07 % | 2,29 M | |
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |
- Bolsa de valores
- Acciones
- Acción CNSP
- Empresa CNS Pharmaceuticals, Inc.